Date of birth: Address:
University Heart Center, Hamburg Clinic for General and Interventional Cardiology
Specialty: Scientific career: 1989 - 1996
Studies of Medicine at Johannes Gutenberg-University, Mainz, Johann Wolfgang Goethe-University, Frankfurt and Mount Sinai Medical School, New York
1996 - 2002
Wissenschaftlicher Assistent (resident and fellow) at the
Department of Medicine II, Johannes Gutenberg-University
2002 - 2003
INSERM Scholarship for post-doctoral training in “Molecular
Genetics and Genetic Epidemiology” at INSERM U525, Faculté
de Médecine Pitié-Salpétrière Paris, France
2003 – 2005
Wissenschaftlicher Assistent (resident and fellow) at the
Department of Medicine II, Johannes Gutenberg-University
PhD thesis (Habilitation) at the Department of Medicine II, Johannes Gutenberg-University Mainz
2005 - 2011
Senior physician at the Department of Medicine II, Johannes
2005 - 2011
Full Professor of Medicine and Faculty Member of the Johannes Gutenberg-University Mainz
2007 - 2011
Leading senior physician and deputy director of the Department of Medicine II, Johannes Gutenberg University of Mainz
2008 – 2011
Speaker of the “Schwerpunkt Vaskuläre Prävention“ (Interdisciplinary task force “Vascular prevention”) of the Johannes Gutenberg University, Mainz
Director of the Clinic for General and Interventional Cardiology, University Heart Center, Hamburg
Awards and scholarships: Member of the “Studienstiftung des Deutschen Volkes“ (German Merit Foundation) (since 1990); Young Investigator Award in Thrombosis of the European Society of Cardiology (2001); “Förderpreis der Deutschen Herzstiftung 2001” (Young Research Award of the German Heart Foundation 2001); Young Investigator Award of the International Society of Thrombosis and Hemostasis (2001); Robert Müller Award of the Johannes Gutenberg University of Mainz (2002); Young Investigator Award in Clinical Science of the European Society of Cardiology – 2nd winner (2002); “Forschungspreis der Deutschen Herzstiftung 2002” (Research Award of the German Heart Foundation 2002); Scientific Award of the „German Society of Prevention of Cardiovascular Disease“ (2004); “Albert-Fraenkel-Award” of the German Cardiac Society (2007). Membership in international scientific working groups, committees and societies:
German Cardiac Society; German Society for Internal Medicine; Steering Committee member „Functional Genomics“ of the American Heart Association; Steering Committee member of the MORGAM (MONICA, Risk, Genetics, Archiving, and Monograph) Study; Steering Committee member of the „Long Term Intervention with Pravastatin“ Study; principal investigator and Steering Committee member of the Gutenberg HealthStudy.
Drug-Drug Interactions Among Elderly Patients Hospitalized for Drug Toxicity David N. Juurlink, MD, FRCPC Context Drug-drug interactions are a preventable cause of morbidity and mortality, yet their consequences in the community are not well characterized. Objective To determine whether elderly patients admitted to hospital with specific drug toxicities were likely to have been prescribed
Alterations in Gastrointestinal Physiologyafter Roux-En-Y Gastric BypassTodd A Ponsky, MD, Fredrick Brody, MD, FACS, Edward Pucci, MDMorbid obesity is increasing exponentially in the US. Although the Roux-en-Y procedure is an effectiveApproximately 33.3% of Americans were obese in 1991,therapy for weight loss, it alters normal digestion andversus 25.4% in Currently, 54.5% of Americansnutrie